While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...

Algiax Pharmaceuticals, a company committed to developing innovative treatments for chronic neuropathic pain, has released ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

Algiax Pharmaceuticals, a clinical-stage biotech company focused on developing innovative treatments for chronic neuropathic pain, today announced compelling topline data from its Phase 2a clinical ...

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

Allosteric GABAA-receptor modulator AP-325 showed rapid onset as well as long-lasting pain reduction in patients with chronic neuropathic pain in Phase 2a study Data confirm previously reported ...

Yoga can help relieve sciatica pain and even prevent it from returning, as it helps improve spinal alignment and release tension. Here are the poses that help the most.

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global market ...

Botox shots have increased in recent years, not just for cosmetic purposes but also for medical applications. The therapy consists of a purified type of neurotoxin, produced by the bacterium ...